Scientific News Eli Lilly Chief Scientist Daniel M Skovronsky Beware Elected Leaders Who Would Weaken Patents
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Eli Lilly Chief Scientist Daniel M Skovronsky Beware Elected Leaders Who Would Weaken Patents is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Who Named the New COVID-19 Drug Bamlanivimab? | An Interview with Dr. Daniel Skovronsky
Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named COVID-19 treatments. We also discussed the challenges of mass-producing ... Read More
Lilly’s head scientist discusses its GLP-1 pill, Alzheimer’s strategy, and finding promising ideas and startups
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus